1.2c and a rush for the door. Any analysis of the longer term graph would have this plane hitting the ground in the not too distant future. Unless management can pull something out of the hat very soon even the true believers will be joining the line at the exit door. The last results failed to impress the market, investors need to know that management have a clear stratergy to move the company foward.
GSK, Pfizer : holes are appearing in their respiratory assets, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $8.487M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.0¢ | $36.40K | 333.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 121392 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.32pm 01/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |